TY  - GEN 
AU  - Peñalver, Francisco‐Javier
AU  - Márquez, José‐Antonio
AU  - Durán, Soledad
AU  - Giraldo, Pilar
AU  - Martín, Alejandro
AU  - Montalbán, Carlos
AU  - Sancho, Juan-Manuel
AU  - Ramírez, María José
AU  - Terol, María José
AU  - Capote Huelva, Francisco Javier
AU  - Gutiérrez, Antonio
AU  - Sánchez, Blanca
AU  - López, Andrés
AU  - Salar, Antonio
AU  - Rodríguez‐Caravaca, Gil
AU  - Canales, Miguel
AU  - Caballero, María‐Dolores
AU  - GELTAMO (The Spanish Lymphoma Cooperative Group)
PY  - 2019
SN  - 2045-7634
UR  - http://hdl.handle.net/10498/21839
AB  - Background: Consensus is lacking regarding the optimal salvage therapy for patients
with follicular lymphoma who relapse after or are refractory to immunochemotherapy.
Methods: This phase II trial evaluated the efficacy and safety of...
LA  - eng
PB  - WILEY
KW  - bendamustine
KW  - follicular lymphoma
KW  - immunochemotherapy
KW  - refractory
KW  - relapsed
TI  - Response‐adapted treatment with rituximab, bendamustine, mitoxantrone, and dexamethasone followed by rituximab maintenance in patients with relapsed or refractory follicular lymphoma after first‐line immunochemotherapy: Results of the RBMDGELTAMO08 phase II trial
DO  - 10.1002/cam4.2555
ER  -